Thomas James
Neuromusculoskeletal Medicine, Sports Medicine · Warren, OHNPI 1285691196
Payments from drug & device makers
Across 129 payments — averaging $20.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$646
- AbbVie$439
- Bayer$407
- Corcept Therapeutics$234
- Johnson & Johnson$133
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$108
- plus $693 from 15 others
What the payments were for
- Food & beverage$2,660100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $646 |
| AbbVie | 16 | $439 |
| Bayer | 28 | $407 |
| Corcept Therapeutics | 6 | $234 |
| Johnson & Johnson | 8 | $133 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $108 |
| Novo Nordisk | 6 | $97 |
| Lilly USA, LLC | 6 | $95 |
| Amgen | 5 | $85 |
| E.r. Squibb & Sons, L.L.C. | 4 | $75 |
| Novartis | 4 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
| Abbott | 2 | $39 |
| GSK | 2 | $34 |
| Boehringer Ingelheim | 2 | $28 |
| Exact Sciences | 1 | $25 |
| Merck | 2 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few neuromusculoskeletal medicine, sports medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $69,376 |
| FarxigaDapagliflozin Propanediol | 34 | $40,859 |
| JanuviaSitagliptin Phosphate | 39 | $32,350 |
| JardianceEmpagliflozin | 20 | $28,823 |
| OzempicSemaglutide | 25 | $25,053 |
| XareltoRivaroxaban | 14 | $20,908 |
| Levothyroxine Sodium | 348 | $4,008 |
| Potassium Chloride | 95 | $3,279 |
| Atorvastatin Calcium | 262 | $2,632 |
| Metoprolol Succinate | 128 | $2,062 |
| SynthroidLevothyroxine Sodium | 47 | $1,824 |
| Omeprazole | 166 | $1,770 |
| Losartan Potassium | 150 | $1,310 |
| Pravastatin Sodium | 93 | $1,242 |
| Pantoprazole Sodium | 87 | $1,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $646 | $40,85934 claims |
| MerckJanuvia | $24 | $32,35039 claims |
| Boehringer IngelheimJardiance | $28 | $28,82320 claims |
| Novo NordiskOzempic | $97 | $25,05325 claims |
| Johnson & JohnsonXarelto | $133 | $20,90814 claims |
| AbbVieSynthroid | $439 | $1,82447 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few neuromusculoskeletal medicine, sports medicine providers in Ohioon file to place this against a meaningful peer group, so we don't.
Other neuromusculoskeletal medicine, sports medicine in Warren
- Richard RayOberlin$2K
- Kempsager RavishankarCleveland$539
- Jeffrey SpencerFredericktown$492
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.